| Year |
Citation |
Score |
| 2022 |
Gunderson CC, Radhakrishnan R, Gomathinayagam R, Husain S, Aravindan S, Moore KM, Dhanasekaran DN, Jayaraman M. Circulating Tumor Cell-Free DNA Genes as Prognostic Gene Signature for Platinum Resistant Ovarian Cancer Diagnosis. Biomarker Insights. 17: 11772719221088404. PMID 35370397 DOI: 10.1177/11772719221088404 |
0.505 |
|
| 2021 |
Ferraresi A, Esposito A, Girone C, Vallino L, Salwa A, Ghezzi I, Thongchot S, Vidoni C, Dhanasekaran DN, Isidoro C. Resveratrol Contrasts LPA-Induced Ovarian Cancer Cell Migration and Platinum Resistance by Rescuing Hedgehog-Mediated Autophagy. Cells. 10. PMID 34831435 DOI: 10.3390/cells10113213 |
0.364 |
|
| 2021 |
Ha JH, Jayaraman M, Yan M, Dhanasekaran P, Isidoro C, Song YS, Dhanasekaran DN. -Regulated Transcriptome and Its Therapeutic Significance in Ovarian Cancer. Biomolecules. 11. PMID 34439877 DOI: 10.3390/biom11081211 |
0.355 |
|
| 2021 |
Ha JH, Jayaraman M, Yan M, Dhanasekaran P, Isidoro C, Song YS, Dhanasekaran DN. Identification of -driven gene signatures and key signaling networks in ovarian cancer. Oncology Letters. 22: 719. PMID 34429759 DOI: 10.3892/ol.2021.12980 |
0.348 |
|
| 2020 |
Xiong X, Rao G, Roy RV, Zhang Y, Means N, Dey A, Tsaliki M, Saha S, Bhattacharyya S, Dhar Dwivedi SK, Rao CV, McCormick DJ, Dhanasekaran D, Ding K, Gillies E, et al. Ubiquitin-binding associated protein 2 regulates KRAS activation and macropinocytosis in pancreatic cancer. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 32692445 DOI: 10.1096/Fj.201902826Rr |
0.466 |
|
| 2020 |
Ha JH, Jayaraman M, Radhakrishnan R, Gomathinayagam R, Yan M, Song YS, Isidoro C, Dhanasekaran DN. Differential effects of thymoquinone on lysophosphatidic acid-induced oncogenic pathways in ovarian cancer cells. Journal of Traditional and Complementary Medicine. 10: 207-216. PMID 32670815 DOI: 10.1016/J.Jtcme.2020.04.001 |
0.607 |
|
| 2020 |
Gunderson C, Evans E, Radhakrishnan R, Gomathinayagam R, Husain S, Aravindan S, Moore K, Dhanasekaran D, Jayaraman M. Circulating Tumor Cell-Free DNA Genes As Biomarkers For Platinum Resistant Ovarian Cancer Diagnosis Gynecologic Oncology. 156: e3-e4. DOI: 10.1016/J.Ygyno.2019.11.043 |
0.497 |
|
| 2020 |
Ha JH, Jayaraman M, Radhakrishnan R, Gomathinayagam R, Yan M, Song YS, Isidoro C, Dhanasekaran DN. Differential effects of thymoquinone on lysophosphatidic acid-induced oncogenic pathways in ovarian cancer cells Journal of Traditional and Complementary Medicine. 10: 207-216. DOI: 10.1016/j.jtcme.2020.04.001 |
0.588 |
|
| 2018 |
Radhakrishnan R, Ha JH, Jayaraman M, Liu J, Moxley K, Isidoro C, Sood AK, Song YS, Dhanasekaran DN. Ovarian Cancer Cell-derived Lysophosphatidic Acid Induces Glycolytic Shift and Cancer-associated Fibroblast-Phenotype in Normal and Peritumoral Fibroblasts. Cancer Letters. PMID 30503552 DOI: 10.1016/J.Canlet.2018.11.023 |
0.582 |
|
| 2018 |
Ha JH, Radhakrishnan R, Jayaraman M, Yan M, Ward JD, Fung KM, Moxley KM, Sood AK, Isidoro C, Mukherjee P, Song YS, Dhanasekaran DN. Lysophosphatidic Acid Induces Metabolic Reprogramming in Ovarian Cancer via a Pseudohypoxic Response. Cancer Research. PMID 29386184 DOI: 10.1158/0008-5472.Can-17-1624 |
0.583 |
|
| 2017 |
Dhanasekaran DN, Reddy EP. JNK-signaling: A multiplexing hub in programmed cell death. Genes & Cancer. 8: 682-694. PMID 29234486 DOI: 10.18632/genesandcancer.155 |
0.321 |
|
| 2017 |
Ferraresi A, Titone R, Follo C, Castiglioni A, Chiorino G, Dhanasekaran DN, Isidoro C. The protein restriction mimetic Resveratrol is an autophagy inducer stronger than amino acid starvation in ovarian cancer cells. Molecular Carcinogenesis. PMID 28856729 DOI: 10.1002/mc.22711 |
0.326 |
|
| 2017 |
Jayaraman M, Radhakrishnan R, Mathews CA, Yan M, Husain S, Moxley KM, Song YS, Dhanasekaran DN. Identification of novel diagnostic and prognostic miRNA signatures in endometrial cancer. Genes & Cancer. 8: 566-576. PMID 28740575 DOI: 10.18632/Genesandcancer.144 |
0.454 |
|
| 2017 |
Chakraborty PK, Mustafi SB, Xiong X, Dwivedi SKD, Nesin V, Saha S, Zhang M, Dhanasekaran D, Jayaraman M, Mannel R, Moore K, McMeekin S, Yang D, Zuna R, Ding K, et al. MICU1 drives glycolysis and chemoresistance in ovarian cancer. Nature Communications. 8: 14634. PMID 28530221 DOI: 10.1038/Ncomms14634 |
0.394 |
|
| 2016 |
Ha JH, Yan M, Gomathinayagam R, Jayaraman M, Husain S, Liu J, Mukherjee P, Reddy EP, Song YS, Dhanasekaran DN. Aberrant expression of JNK-associated leucine-zipper protein, JLP, promotes accelerated growth of ovarian cancer. Oncotarget. PMID 27655714 DOI: 10.18632/oncotarget.12069 |
0.398 |
|
| 2016 |
Srivastava A, Babu A, Filant J, Moxley KM, Ruskin R, Dhanasekaran D, Sood AK, McMeekin S, Ramesh R. Exploitation of Exosomes as Nanocarriers for Gene-, Chemo-, and Immune-Therapy of Cancer. Journal of Biomedical Nanotechnology. 12: 1159-73. PMID 27319211 DOI: 10.1166/Jbn.2016.2205 |
0.319 |
|
| 2016 |
Ha JH, Ward JD, Radhakrishnan R, Jayaraman M, Song YS, Dhanasekaran DN. Lysophosphatidic acid stimulates epithelial to mesenchymal transition marker Slug/Snail2 in ovarian cancer cells via Gαi2, Src, and HIF1α signaling nexus. Oncotarget. PMID 27166196 DOI: 10.18632/Oncotarget.9224 |
0.608 |
|
| 2016 |
Gwak H, Kim Y, An H, Dhanasekaran DN, Song YS. Metformin induces degradation of cyclin D1 via AMPK/GSK3β axis in ovarian cancer. Molecular Carcinogenesis. PMID 27128966 DOI: 10.1002/mc.22498 |
0.343 |
|
| 2015 |
Gwak H, Kim S, Dhanasekaran DN, Song YS. Resveratrol triggers ER stress-mediated apoptosis by disrupting N-linked glycosylation of proteins in ovarian cancer cells. Cancer Letters. PMID 26704305 DOI: 10.1016/j.canlet.2015.11.032 |
0.362 |
|
| 2015 |
Chakraborty PK, Xiong X, Mustafi SB, Saha S, Dhanasekaran D, Mandal NA, McMeekin S, Bhattacharya R, Mukherjee P. Role of cystathionine beta synthase in lipid metabolism in ovarian cancer. Oncotarget. PMID 26452259 DOI: 10.18632/Oncotarget.5424 |
0.369 |
|
| 2015 |
Ha JH, Gomathinayagam R, Yan M, Jayaraman M, Ramesh R, Dhanasekaran DN. Determinant role for the gep oncogenes, Gα12/13, in ovarian cancer cell proliferation and xenograft tumor growth. Genes & Cancer. 6: 356-64. PMID 26413218 |
0.385 |
|
| 2015 |
Ward JD, Ha JH, Jayaraman M, Dhanasekaran DN. LPA-mediated migration of ovarian cancer cells involves translocalization of Gαi2 to invadopodia and association with Src and β-pix. Cancer Letters. 356: 382-91. PMID 25451317 DOI: 10.1016/j.canlet.2014.09.030 |
0.443 |
|
| 2015 |
Ha JH, Radhakrishnan R, Dhanasekaran D. Abstract 1141: LPA stimulates glycolytic shift of ovarian cancer cells via gip2 oncogenes Cancer Research. 75: 1141-1141. DOI: 10.1158/1538-7445.Am2015-1141 |
0.647 |
|
| 2014 |
Gomathinayagam R, Muralidharan J, Ha JH, Varadarajalu L, Dhanasekaran DN. Hax-1 is required for Rac1-Cortactin interaction and ovarian carcinoma cell migration. Genes & Cancer. 5: 84-99. PMID 25053987 |
0.377 |
|
| 2014 |
Dhanasekaran D. G protein signaling in tumor cell growth and metastasis. Molecular Cytogenetics. 7: I56. PMID 24940381 DOI: 10.1186/1755-8166-7-S1-I56 |
0.348 |
|
| 2014 |
Ha JH, Ward JD, Varadarajalu L, Kim SG, Dhanasekaran DN. The gep proto-oncogene Gα12 mediates LPA-stimulated activation of CREB in ovarian cancer cells. Cellular Signalling. 26: 122-32. PMID 24055910 DOI: 10.1016/j.cellsig.2013.08.012 |
0.437 |
|
| 2014 |
Mathews CA, Jayaraman M, Thomas E, Tuller E, Dhanasekaran D, McMeekin DS. Advanced endometrial cancer patients: Who responds to standard chemotherapy? Journal of Clinical Oncology. 32: e16542-e16542. DOI: 10.1200/Jco.2014.32.15_Suppl.E16542 |
0.305 |
|
| 2013 |
Gardner JA, Ha JH, Jayaraman M, Dhanasekaran DN. The gep proto-oncogene Gα13 mediates lysophosphatidic acid-mediated migration of pancreatic cancer cells. Pancreas. 42: 819-28. PMID 23508014 DOI: 10.1097/Mpa.0B013E318279C577 |
0.584 |
|
| 2013 |
Ha JH, Dhanasekaran D, Ward J, Yang YM, Kim SG, Varadarajalu L. Abstract 3020: The gep protooncogene Gα12 mediates LPA-stimulated activation of CREB in ovarian cancer cells. Cancer Research. 73: 3020-3020. DOI: 10.1158/1538-7445.Am2013-3020 |
0.496 |
|
| 2012 |
Ward JD, Dhanasekaran DN. LPA Stimulates the Phosphorylation of p130Cas via Gαi2 in Ovarian Cancer Cells. Genes & Cancer. 3: 578-91. PMID 23486563 DOI: 10.1177/1947601913475360 |
0.455 |
|
| 2011 |
Goldsmith ZG, Ha JH, Jayaraman M, Dhanasekaran DN. Lysophosphatidic Acid Stimulates the Proliferation of Ovarian Cancer Cells via the gep Proto-Oncogene Gα(12). Genes & Cancer. 2: 563-75. PMID 21901169 DOI: 10.1177/1947601911419362 |
0.736 |
|
| 2011 |
Kashef K, Radhakrishnan R, Lee CM, Reddy EP, Dhanasekaran DN. Neoplastic transformation induced by the gep oncogenes involves the scaffold protein JNK-interacting leucine zipper protein. Neoplasia (New York, N.Y.). 13: 358-64. PMID 21472140 DOI: 10.1593/Neo.101622 |
0.725 |
|
| 2010 |
Radhakrishnan R, Ha JH, Dhanasekaran DN. Mitogenic Signaling by the gep Oncogene Involves the Upregulation of S-Phase Kinase-Associated Protein 2. Genes & Cancer. 1: 1033-43. PMID 21533006 DOI: 10.1177/1947601910390516 |
0.651 |
|
| 2010 |
Yang YM, Lee S, Nam CW, Ha JH, Jayaraman M, Dhanasekaran DN, Lee CH, Kwak MK, Kim SG. G(alpha)12/13 inhibition enhances the anticancer effect of bortezomib through PSMB5 downregulation. Carcinogenesis. 31: 1230-7. PMID 20478922 DOI: 10.1093/carcin/bgq097 |
0.319 |
|
| 2010 |
Xu H, Dhanasekaran DN, Lee CM, Reddy EP. Regulation of neurite outgrowth by interactions between the scaffolding protein, JNK-associated leucine zipper protein, and neuronal growth-associated protein superior cervical ganglia clone 10. The Journal of Biological Chemistry. 285: 3548-53. PMID 19959466 DOI: 10.1074/Jbc.M109.064113 |
0.302 |
|
| 2010 |
Dhanasekaran DN, Reddy EP. Mitogen-activated protein kinases and their scaffolding proteins Signal Transduction: Pathways, Mechanisms and Diseases. 219-236. DOI: 10.1007/978-3-642-02112-1_12 |
0.373 |
|
| 2008 |
Jalagadugula GS, Kaur G, Mao G, Dhanasekaran D, Rao AK. Platelet/Megakaryocyte PKC-Θ Is a Transcriptional Target of RUNX1/ CBFA2: Studies in Human RUNX1 Haplodeficiency. Blood. 112: 1846-1846. DOI: 10.1182/Blood.V112.11.1846.1846 |
0.332 |
|
| 2007 |
Dhanasekaran DN, Kashef K, Lee CM, Xu H, Reddy EP. Scaffold proteins of MAP-kinase modules. Oncogene. 26: 3185-202. PMID 17496915 DOI: 10.1038/Sj.Onc.1210411 |
0.739 |
|
| 2007 |
Goldsmith ZG, Dhanasekaran DN. G protein regulation of MAPK networks. Oncogene. 26: 3122-42. PMID 17496911 DOI: 10.1038/sj.onc.1210407 |
0.751 |
|
| 2006 |
Dhanasekaran DN. Transducing the signals: a G protein takes a new identity. Science's Stke : Signal Transduction Knowledge Environment. 2006: pe31. PMID 16896192 DOI: 10.1126/stke.3472006pe31 |
0.358 |
|
| 2006 |
Kashef K, Xu H, Reddy EP, Dhanasekaran DN. Endodermal differentiation of murine embryonic carcinoma cells by retinoic acid requires JLP, a JNK-scaffolding protein. Journal of Cellular Biochemistry. 98: 715-22. PMID 16619266 DOI: 10.1002/Jcb.20930 |
0.735 |
|
| 2006 |
Kumar RN, Ha JH, Radhakrishnan R, Dhanasekaran DN. Transactivation of platelet-derived growth factor receptor alpha by the GTPase-deficient activated mutant of Galpha12. Molecular and Cellular Biology. 26: 50-62. PMID 16354679 DOI: 10.1128/MCB.26.1.50-62.2006 |
0.598 |
|
| 2005 |
Kashef K, Lee CM, Ha JH, Reddy EP, Dhanasekaran DN. JNK-interacting leucine zipper protein is a novel scaffolding protein in the Galpha13 signaling pathway. Biochemistry. 44: 14090-6. PMID 16245925 DOI: 10.1021/Bi050604L |
0.759 |
|
| 2005 |
Reece EA, Ma XD, Zhao Z, Wu YK, Dhanasekaran D. Aberrant patterns of cellular communication in diabetes-induced embryopathy in rats: II, apoptotic pathways. American Journal of Obstetrics and Gynecology. 192: 967-72. PMID 15746699 DOI: 10.1016/J.Ajog.2004.10.592 |
0.328 |
|
| 1997 |
Luthin GR, Wang P, Zhou H, Dhanasekaran D, Ruggieri MR. Role of m1 receptor-G protein coupling in cell proliferation in the prostate. Life Sciences. 60: 963-8. PMID 9121362 DOI: 10.1016/S0024-3205(97)00035-0 |
0.372 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2016 |
Kim B, Kim HS, Kim S, Haegeman G, Tsang BK, Dhanasekaran DN, Song YS. Adipose Stromal Cells from Visceral and Subcutaneous Fat Facilitate Migration of Ovarian Cancer Cells via IL-6/JAK2/STAT3 Pathway. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 27456942 DOI: 10.4143/crt.2016.175 |
0.296 |
|
| 2008 |
Jalagadugula GS, Kaur G, Mao G, Dhanasekaran D, Rao AK. RUNX1/CBFA2 Regulates Myosin Light Chain 9 (MYL9) in Megakaryocytic Cells: Decreased MYL9 Expression in Human RUNX1 Haplodeficiency. Blood. 112: 1831-1831. DOI: 10.1182/Blood.V112.11.1831.1831 |
0.291 |
|
| 2009 |
Suzuki H, Kimura K, Shirai H, Eguchi K, Higuchi S, Hinoki A, Ishimaru K, Brailoiu E, Dhanasekaran DN, Stemmle LN, Fields TA, Frank GD, Autieri MV, Eguchi S. Endothelial nitric oxide synthase inhibits G12/13 and rho-kinase activated by the angiotensin II type-1 receptor: implication in vascular migration. Arteriosclerosis, Thrombosis, and Vascular Biology. 29: 217-24. PMID 19095998 DOI: 10.1161/Atvbaha.108.181024 |
0.291 |
|
| 2021 |
Kim S, Han Y, Kim SI, Lee J, Jo H, Wang W, Cho U, Park WY, Rando TA, Dhanasekaran DN, Song YS. Computational modeling of malignant ascites reveals CCL5-SDC4 interaction in the immune microenvironment of ovarian cancer. Molecular Carcinogenesis. PMID 33721368 DOI: 10.1002/mc.23289 |
0.285 |
|
| 2006 |
Reece EA, Wu YK, Zhao Z, Dhanasekaran D. Dietary vitamin and lipid therapy rescues aberrant signaling and apoptosis and prevents hyperglycemia-induced diabetic embryopathy in rats. American Journal of Obstetrics and Gynecology. 194: 580-5. PMID 16458664 DOI: 10.1016/J.Ajog.2005.08.052 |
0.283 |
|
| 2021 |
Ha JH, Jayaraman M, Nadhan R, Kashyap S, Mukherjee P, Isidoro C, Song YS, Dhanasekaran DN. Unraveling Autocrine Signaling Pathways through Metabolic Fingerprinting in Serous Ovarian Cancer Cells. Biomedicines. 9. PMID 34944743 DOI: 10.3390/biomedicines9121927 |
0.283 |
|
| 2017 |
Ali N, Nguyen CB, Chandrakesan P, May R, Dhanasekaran D, Bronze MS, Houchen CW. Abstract 3884: A tumor stem cell marker DCLK1 promotes hepatocellular carcinoma by regulating β-catenin, EMT and clonogenic properties of hepatocytes Cancer Research. 77: 3884-3884. DOI: 10.1158/1538-7445.Am2017-3884 |
0.282 |
|
| 2020 |
Ferraresi A, Girone C, Esposito A, Vidoni C, Vallino L, Secomandi E, Dhanasekaran DN, Isidoro C. How Autophagy Shapes the Tumor Microenvironment in Ovarian Cancer. Frontiers in Oncology. 10: 599915. PMID 33364196 DOI: 10.3389/fonc.2020.599915 |
0.28 |
|
| 2020 |
Gomathinayagam R, Ha JH, Jayaraman M, Song YS, Isidoro C, Dhanasekaran DN. Chemopreventive and Anticancer Effects of Thymoquinone: Cellular and Molecular Targets. Journal of Cancer Prevention. 25: 136-151. PMID 33033708 DOI: 10.15430/JCP.2020.25.3.136 |
0.278 |
|
| 2023 |
Vidoni C, Ferraresi A, Vallino L, Salwa A, Ha JH, Seca C, Garavaglia B, Dhanasekaran DN, Isidoro C. Glycolysis Inhibition of Autophagy Drives Malignancy in Ovarian Cancer: Exacerbation by IL-6 and Attenuation by Resveratrol. International Journal of Molecular Sciences. 24. PMID 36675246 DOI: 10.3390/ijms24021723 |
0.278 |
|
| 2015 |
Yan M, Ha JH, Dhanasekaran DN. Gα13 Stimulates the Tyrosine Phosphorylation of Ric-8A. Journal of Molecular Signaling. 10: 3. PMID 27096001 DOI: 10.5334/1750-2187-10-3 |
0.275 |
|
| 2022 |
Esposito A, Ferraresi A, Salwa A, Vidoni C, Dhanasekaran DN, Isidoro C. Resveratrol Contrasts IL-6 Pro-Growth Effects and Promotes Autophagy-Mediated Cancer Cell Dormancy in 3D Ovarian Cancer: Role of miR-1305 and of Its Target ARH-I. Cancers. 14. PMID 35565270 DOI: 10.3390/cancers14092142 |
0.274 |
|
| 2008 |
Jalagadugula G, Dhanasekaran DN, Rao AK. Phorbol 12-myristate 13-acetate (PMA) responsive sequence in Galphaq promoter during megakaryocytic differentiation. Regulation by EGR-1 and MAP kinase pathway. Thrombosis and Haemostasis. 100: 821-8. PMID 18989526 DOI: 10.1160/TH08-07-0496 |
0.272 |
|
| 2019 |
Han Y, Jo H, Cho JH, Dhanasekaran DN, Song YS. Resveratrol as a Tumor-Suppressive Nutraceutical Modulating Tumor Microenvironment and Malignant Behaviors of Cancer. International Journal of Molecular Sciences. 20. PMID 30791624 DOI: 10.3390/ijms20040925 |
0.265 |
|
| 2015 |
Seo JA, Kim B, Dhanasekaran DN, Tsang BK, Song YS. Curcumin induces apoptosis by inhibiting sarco/endoplasmic reticulum ca(2+) ATPase activity in ovarian cancer cells. Cancer Letters. PMID 26607901 DOI: 10.1016/j.canlet.2015.11.021 |
0.261 |
|
| 2019 |
Vidoni C, Ferraresi A, Secomandi E, Vallino L, Dhanasekaran DN, Isidoro C. Epigenetic targeting of autophagy for cancer prevention and treatment by natural compounds. Seminars in Cancer Biology. PMID 31054926 DOI: 10.1016/j.semcancer.2019.04.006 |
0.26 |
|
| 2013 |
Dhanasekaran DN. JNK Signaling Network and Cancer. Genes & Cancer. 4: 332-3. PMID 24349630 DOI: 10.1177/1947601913507949 |
0.255 |
|
| 2020 |
Vallino L, Ferraresi A, Vidoni C, Secomandi E, Esposito A, Dhanasekaran DN, Isidoro C. Modulation of non-coding RNAs by resveratrol in ovarian cancer cells: In silico analysis and literature review of the anti-cancer pathways involved Journal of Traditional and Complementary Medicine. 10: 217-229. DOI: 10.1016/j.jtcme.2020.02.006 |
0.252 |
|
| 2023 |
Nadhan R, Kashyap S, Ha JH, Jayaraman M, Song YS, Isidoro C, Dhanasekaran DN. Targeting Oncometabolites in Peritoneal Cancers: Preclinical Insights and Therapeutic Strategies. Metabolites. 13. PMID 37233659 DOI: 10.3390/metabo13050618 |
0.249 |
|
| 2020 |
Wang W, Im J, Kim S, Jang S, Han Y, Yang KM, Kim SJ, Dhanasekaran DN, Song YS. ROS-Induced SIRT2 Upregulation Contributes to Cisplatin Sensitivity in Ovarian Cancer. Antioxidants (Basel, Switzerland). 9. PMID 33207824 DOI: 10.3390/antiox9111137 |
0.246 |
|
| 2022 |
Nadhan R, Isidoro C, Song YS, Dhanasekaran DN. Signaling by LncRNAs: Structure, Cellular Homeostasis, and Disease Pathology. Cells. 11. PMID 36010595 DOI: 10.3390/cells11162517 |
0.245 |
|
| 2007 |
Sun L, Mao G, Kunapuli SP, Dhanasekaran DN, Rao AK. Alternative splice variants of phospholipase C-beta2 are expressed in platelets: effect on Galphaq-dependent activation and localization. Platelets. 18: 217-23. PMID 17497434 DOI: 10.1080/09537100601016133 |
0.237 |
|
| 2020 |
Vallino L, Ferraresi A, Vidoni C, Secomandi E, Esposito A, Dhanasekaran DN, Isidoro C. Modulation of non-coding RNAs by resveratrol in ovarian cancer cells: analysis and literature review of the anti-cancer pathways involved. Journal of Traditional and Complementary Medicine. 10: 217-229. PMID 32670816 DOI: 10.1016/j.jtcme.2020.02.006 |
0.235 |
|
| 2018 |
Kim S, Lee M, Dhanasekaran DN, Song YS. Activation of LXRɑ/β by cholesterol in malignant ascites promotes chemoresistance in ovarian cancer. Bmc Cancer. 18: 1232. PMID 30526541 DOI: 10.1186/s12885-018-5152-5 |
0.233 |
|
| 2018 |
Chakraborty PK, Murphy B, Mustafi SB, Dey A, Xiong X, Rao G, Naz S, Zhang M, Yang D, Dhanasekaran DN, Bhattacharya R, Mukherjee P. Cystathionine β-synthase regulates mitochondrial morphogenesis in ovarian cancer. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. fj201701095R. PMID 29494264 DOI: 10.1096/fj.201701095R |
0.232 |
|
| 2017 |
Kim B, Jung JW, Jung J, Han Y, Suh DH, Kim HS, Dhanasekaran DN, Song YS. PGC1α induced by reactive oxygen species contributes to chemoresistance of ovarian cancer cells. Oncotarget. 8: 60299-60311. PMID 28947972 DOI: 10.18632/oncotarget.19140 |
0.228 |
|
| 2021 |
Salwa A, Ferraresi A, Chinthakindi M, Vallino L, Vidoni C, Dhanasekaran DN, Isidoro C. and Deficiency Sensitizes Ovarian Cancer to Platinum Therapy and Confers Better Prognosis. Biomedicines. 9. PMID 33670664 DOI: 10.3390/biomedicines9020207 |
0.223 |
|
| 2006 |
Jalagadugula G, Dhanasekaran DN, Kim S, Kunapuli SP, Rao AK. Early growth response transcription factor EGR-1 regulates Galphaq gene in megakaryocytic cells. Journal of Thrombosis and Haemostasis : Jth. 4: 2678-86. PMID 16995904 DOI: 10.1111/J.1538-7836.2006.02229.X |
0.223 |
|
| 2014 |
Song YS, Kim HS, Aoki D, Dhanasekaran DN, Tsang BK. Ovarian cancer. Biomed Research International. 2014: 764323. PMID 25587539 DOI: 10.1155/2014/764323 |
0.208 |
|
| 2018 |
Han Y, Cho U, Kim S, Sil Park I, Cho JH, Dhanasekaran DN, Song YS. Tumor microenvironment on mitochondrial dynamics and chemoresistance in cancer. Free Radical Research. 1-411. PMID 29607684 DOI: 10.1080/10715762.2018.1459594 |
0.207 |
|
| 2019 |
Han Y, Kim B, Cho U, Park IS, Kim SI, Dhanasekaran DN, Tsang BK, Song YS. Mitochondrial fission causes cisplatin resistance under hypoxic conditions via ROS in ovarian cancer cells. Oncogene. PMID 31409904 DOI: 10.1038/s41388-019-0949-5 |
0.207 |
|
| 2016 |
Kim S, Gwak H, Kim HS, Kim B, Dhanasekaran DN, Song YS. Malignant ascites enhances migratory and invasive properties of ovarian cancer cells with membrane bound IL-6R in vitro. Oncotarget. PMID 27825119 DOI: 10.18632/oncotarget.13074 |
0.206 |
|
| 2021 |
Lee J, Han Y, Wang W, Jo H, Kim H, Kim S, Yang KM, Kim SJ, Dhanasekaran DN, Song YS. Phytochemicals in Cancer Immune Checkpoint Inhibitor Therapy. Biomolecules. 11. PMID 34439774 DOI: 10.3390/biom11081107 |
0.203 |
|
| 2016 |
Nguyen CB, Kotturi H, Waris G, Mohammed A, Chandrakesan P, May R, Sureban S, Weygant N, Qu D, Rao C, Dhanasekaran DN, Bronze MS, Houchen CW, Ali N. (Z)-3,5,4'-Trimethoxystilbene Limits Hepatitis C and Cancer Pathophysiology by Blocking Microtubule Dynamics and Cell Cycle Progression. Cancer Research. PMID 27287718 DOI: 10.1158/0008-5472.Can-15-2722 |
0.197 |
|
| 2009 |
Dhanasekaran DN, Radhika V, Proikas-Cezanne T, Jayaraman M, Ha J. Heterologous expression of olfactory receptors for targeted chemosensing. Annals of the New York Academy of Sciences. 1170: 157-60. PMID 19686128 DOI: 10.1111/j.1749-6632.2009.04374.x |
0.194 |
|
| 2010 |
Reddy HK, Graña X, Dhanasekaran DN, Litvin J, Reddy EP. Requirement of Cdk4 for v-Ha-ras-Induced Breast Tumorigenesis and Activation of the v-ras-Induced Senescence Program by the R24C Mutation. Genes & Cancer. 1: 69-80. PMID 20634902 DOI: 10.1177/1947601909358105 |
0.194 |
|
| 2022 |
Vidoni C, Ferraresi A, Esposito A, Maheshwari C, Dhanasekaran DN, Mollace V, Isidoro C. Calorie Restriction for Cancer Prevention and Therapy: Mechanisms, Expectations, and Efficacy. Journal of Cancer Prevention. 26: 224-236. PMID 35047448 DOI: 10.15430/JCP.2021.26.4.224 |
0.194 |
|
| 2015 |
Ali N, Chandrakesan P, Nguyen CB, Husain S, Gillaspy AF, Huycke M, Berry WL, May R, Qu D, Weygant N, Sureban SM, Bronze MS, Dhanasekaran DN, Houchen CW. Inflammatory and oncogenic roles of a tumor stem cell marker doublecortin-like kinase (DCLK1) in virus-induced chronic liver diseases. Oncotarget. PMID 25948779 |
0.192 |
|
| 2002 |
Gabbeta J, Vaidyula VR, Dhanasekaran DN, Rao AK. Human Platelet Gαq Deficiency Is Associated with Decreased Gαq Gene Expression in Platelets but not Neutrophils Thrombosis and Haemostasis. 87: 129-133. DOI: 10.1055/s-0037-1612955 |
0.181 |
|
| 2006 |
Dhanasekaran DN. An open access journal of molecular signaling: a critical need at a critical time. Journal of Molecular Signaling. 1: 1. PMID 17224077 DOI: 10.1186/1750-2187-1-1 |
0.178 |
|
| 2011 |
Jalagadugula G, Mao G, Kaur G, Dhanasekaran DN, Rao AK. Platelet protein kinase C-theta deficiency with human RUNX1 mutation: PRKCQ is a transcriptional target of RUNX1. Arteriosclerosis, Thrombosis, and Vascular Biology. 31: 921-7. PMID 21252065 DOI: 10.1161/ATVBAHA.110.221879 |
0.171 |
|
| 2017 |
Xia D, Lai DV, Wu W, Webb ZD, Yang Q, Zhao L, Yu Z, Thorpe JE, Disch BC, Ihnat MA, Jayaraman M, Dhanasekaran DN, Stratton KL, Cookson MS, Fung KM, et al. Transition from androgenic to neurosteroidal action of 5α-androstane-3α, 17β-diol through the type A γ-aminobutyric acid receptor in prostate cancer progression. The Journal of Steroid Biochemistry and Molecular Biology. PMID 29155210 DOI: 10.1016/j.jsbmb.2017.11.006 |
0.171 |
|
| 2022 |
Yan F, Ha JH, Yan Y, Ton SB, Wang C, Mutembei B, Alhajeri ZA, McNiel AF, Keddissi AJ, Zhang Q, Jayaraman M, Dhanasekaran DN, Tang Q. Optical Coherence Tomography of Tumor Spheroids Identifies Candidates for Drug Repurposing in Ovarian Cancer. Ieee Transactions On Bio-Medical Engineering. PMID 37015385 DOI: 10.1109/TBME.2022.3231835 |
0.155 |
|
| 2012 |
Singhal A, Jayaraman M, Dhanasekaran DN, Kohli V. Molecular and serum markers in hepatocellular carcinoma: predictive tools for prognosis and recurrence. Critical Reviews in Oncology/Hematology. 82: 116-40. PMID 21680198 DOI: 10.1016/j.critrevonc.2011.05.005 |
0.153 |
|
| 2010 |
Jalagadugula G, Mao G, Kaur G, Goldfinger LE, Dhanasekaran DN, Rao AK. Regulation of platelet myosin light chain (MYL9) by RUNX1: implications for thrombocytopenia and platelet dysfunction in RUNX1 haplodeficiency. Blood. 116: 6037-45. PMID 20876458 DOI: 10.1182/blood-2010-06-289850 |
0.148 |
|
| 2023 |
Roy RV, Means N, Rao G, Asfa S, Madka V, Dey A, Zhang Y, Choudhury M, Fung KM, Dhanasekaran DN, Friedman JE, Crawford HC, Rao CV, Bhattacharya R, Mukherjee P. Pancreatic Ubap2 deletion regulates glucose tolerance, inflammation, and protection from cerulein-induced pancreatitis. Cancer Letters. 216455. PMID 37865160 DOI: 10.1016/j.canlet.2023.216455 |
0.146 |
|
| 2022 |
Wang W, Jo H, Park S, Kim H, Kim SI, Han Y, Lee J, Seol A, Kim J, Lee M, Lee C, Dhanasekaran DN, Ahn T, Song YS. Integrated analysis of ascites and plasma extracellular vesicles identifies a miRNA-based diagnostic signature in ovarian cancer. Cancer Letters. 215735. PMID 35569696 DOI: 10.1016/j.canlet.2022.215735 |
0.139 |
|
| 2007 |
Radhika V, Proikas-Cezanne T, Jayaraman M, Onesime D, Ha JH, Dhanasekaran DN. Chemical sensing of DNT by engineered olfactory yeast strain. Nature Chemical Biology. 3: 325-30. PMID 17486045 DOI: 10.1038/nchembio882 |
0.138 |
|
| 2020 |
Kim SI, Kang N, Leem S, Yang J, Jo H, Lee M, Kim HS, Dhanasekaran DN, Kim YK, Park T, Song YS. Metagenomic Analysis of Serum Microbe-Derived Extracellular Vesicles and Diagnostic Models to Differentiate Ovarian Cancer and Benign Ovarian Tumor. Cancers. 12. PMID 32455705 DOI: 10.3390/cancers12051309 |
0.119 |
|
| 2018 |
Srivastava A, Moxley K, Ruskin R, Dhanasekaran DN, Zhao YD, Ramesh R. A Non-invasive Liquid Biopsy Screening of Urine-Derived Exosomes for miRNAs as Biomarkers in Endometrial Cancer Patients. The Aaps Journal. 20: 82. PMID 29987691 DOI: 10.1208/S12248-018-0220-Y |
0.11 |
|
| 2005 |
Jayaraman M, Radhika V, Bamne MN, Ramos R, Briggs R, Dhanasekaran DN. Engineered Saccharomyces cerevisiae strain BioS-OS1/2, for the detection of oxidative stress. Biotechnology Progress. 21: 1373-9. PMID 16209540 DOI: 10.1021/bp050104j |
0.105 |
|
| 2017 |
Ruskin R, Rowland M, Dhanasekaran D, Jayaraman M, Moxley K. Clinical and serum predictors of anti-angiogenic toxicity Gynecologic Oncology. 145: 80. DOI: 10.1016/j.ygyno.2017.03.189 |
0.019 |
|
| 2013 |
Dhanasekaran DN. Monographs editor. Genes & Cancer. 4: 331. PMID 24349629 DOI: 10.1177/1947601913507950 |
0.01 |
|
| Hide low-probability matches. |